請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/48412完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 吳英黛(Ying-Tai Wu) | |
| dc.contributor.author | Cian-Ci Liou | en |
| dc.contributor.author | 劉千綺 | zh_TW |
| dc.date.accessioned | 2021-06-15T06:55:48Z | - |
| dc.date.available | 2014-03-03 | |
| dc.date.copyright | 2011-03-03 | |
| dc.date.issued | 2011 | |
| dc.date.submitted | 2011-02-09 | |
| dc.identifier.citation | Abozguia K, Phan TT, Shivu GN, Maher AR, Ahmed I, Wagenmakers A, et al. Reduced in vivo skeletal muscle oxygen consumption in patients with chronic heart failure--a study using Near Infrared Spectrophotometry (NIRS). Eur J Heart Fail 2008;10:652-7.
2. Agarwal SC, Allen J, Murray A, Purcell IF. Comparative reproducibility of dermal microvascular blood flow changes in response to acetylcholine iontophoresis, hyperthermia and reactive hyperaemia. Physiol Meas 2010;31:1-11. 3. Ahmed A. A propensity matched study of New York Heart Association class and natural history end points in heart failure. Am J Cardiol 2007;99:549-53. 4. Alla F, Briancon S, Guillemin F, Juilliere Y, Mertes PM, Villemot JP, et al. Self-rating of quality of life provides additional prognostic information in heart failure. Insights into the EPICAL study. Eur J Heart Fail 2002;4:337-43. 5. Anand IS, Latini R, Florea VG, Kuskowski MA, Rector T, Masson S, et al. C-reactive protein in heart failure: prognostic value and the effect of valsartan. Circulation 2005;112:1428-34. 6. Andersson SE, Edvinsson ML and Edvinsson L. Cutaneous vascular reactivity is reduced in aging and in heart failure: association with inflammation. Clin Sci (Lond) 2003;105:699-707. 7. ATS. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-7. 8. Austin KG, Daigle KA, Patterson P, Cowman J, Chelland S, Haymes EM. Reliability of near-infrared spectroscopy for determining muscle oxygen saturation during exercise. Res Q Exerc Sport 2005;76:440-9. 9. Belardinelli R, Barstow TJ, Nguyen P, Wasserman K. Skeletal muscle oxygenation and oxygen uptake kinetics following constant work rate exercise in chronic congestive heart failure. Am J Cardiol 1997;80:1319-24. 10. Bennet SJ, Oldridge NB, Eckert GJ, Embree JL, Browning S, Hou N, et al. Discriminant properties of commonly used quality of life measures in heart failure. Qual Life Res 2002;11:349-59. 11. Bernjak A, Clarkson PB, McClintock PV, Stefanovska A. Low-frequency blood flow oscillations in congestive heart failure and after beta1-blockade treatment. Microvasc Res 2008;76:224-32. 12. Bleumink GS, Knetsch AM, Sturkenboom MC, Straus SM, Hofman A, Deckers JW, et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study. Eur Heart J 2004;25:1614-9. 13. Bohannon RW. Alternatives for measuring knee extension strength of the elderly at home. Clin Rehabil 1998;12:434-40. 14. Braunstein JB, Anderson GF, Gerstenblith G, Weller W, Niefeld M, Herbert R, et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol 2003;42:1226-33. 15. Brunner F, Bras-Silva C, Cerdeira AS, Leite-Moreira AF. Cardiovascular endothelins: essential regulators of cardiovascular homeostasis. Pharmacol Ther 2006;111:508-31. 16. Buller NP, Jones D and Poole-Wilson PA. Direct measurement of skeletal muscle fatigue in patients with chronic heart failure. Br Heart J 1991;65:20-4. 17. Capuron L, Moranis A, Combe N, Cousson-Gelie F, Fuchs D, De Smedt-Peyrusse V, et al. Vitamin E status and quality of life in the elderly: influence of inflammatory processes. Br J Nutr 2009;102:1390-4. 18. Clark A, Rafferty D and Arbuthnott K. Relationship between isokinetic muscle strength and exercise capacity in chronic heart failure. Int J Cardiol 1997;59:145-8. 19. Cluff LE. Chronic disease, function and the quality of care. J Chronic Dis 1981;34:299-304. 20. Cohen ND, Dunstan DW, Robinson C, Vulikh E, Zimmet PZ, Shaw JE. Improved endothelial function following a 14-month resistance exercise training program in adults with type 2 diabetes. Diabetes Res Clin Pract 2008;79:405-11. 21. Cracowski JL, Minson CT, Salvat-Melis M, Halliwill JR. Methodological issues in the assessment of skin microvascular endothelial function in humans. Trends Pharmacol Sci 2006;27:503-8. 22. Crisafulli A, Salis E, Tocco F, Melis F, Milia R, Pittau G, et al. Impaired central hemodynamic response and exaggerated vasoconstriction during muscle metaboreflex activation in heart failure patients. Am J Physiol Heart Circ Physiol 2007;292:H2988-96. 23. Csuka M and McCarty DJ. Simple method for measurement of lower extremity muscle strength. Am J Med 1985;78:77-81. 24. Demers C, McKelvie RS, Negassa A, Yusuf S. Reliability, validity, and responsiveness of the six-minute walk test in patients with heart failure. Am Heart J 2001;142:698-703. 25. Drexler H, Hayoz D, Munzel T, Hornig B, Just H, Brunner HR, et al. Endothelial function in chronic congestive heart failure. Am J Cardiol 1992a;69:1596-601. 26. Drexler H, Riede U, Munzel T, Konig H, Funke E, Just H. Alterations of skeletal muscle in chronic heart failure. Circulation 1992b;85:1751-9. 27. Dubey L, Zeng HS, Wang HJ, Liu RY. Potential role of adipocytokine leptin in acute coronary syndrome. Asian Cardiovasc Thorac Ann 2008;16:124-8. 28. Duscha BD, Kraus WE, Keteyian SJ, Sullivan MJ, Green HJ, Schachat FH, et al. Capillary density of skeletal muscle: a contributing mechanism for exercise intolerance in class II-III chronic heart failure independent of other peripheral alterations. J Am Coll Cardiol 1999;33:1956-63. 29. Enright PL and Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med 1998;158:1384-7. 30. Fang ZY and Marwick TH. Vascular dysfunction and heart failure: epiphenomenon or etiologic agent? Am Heart J 2002;143:383-90. 31. Farkas K, Kolossvary E, Jarai Z, Nemcsik J, Farsang C. Non-invasive assessment of microvascular endothelial function by laser Doppler flowmetry in patients with essential hypertension. Atherosclerosis 2004;173:97-102. 32. Ferrari M, Mottola L and Quaresima V. Principles, techniques, and limitations of near infrared spectroscopy. Can J Appl Physiol 2004;29:463-87. 33. Ferreira LF, Townsend DK, Lutjemeier BJ, Barstow TJ. Muscle capillary blood flow kinetics estimated from pulmonary O2 uptake and near-infrared spectroscopy. J Appl Physiol 2005;98:1820-8. 34. Florea VG, Mareyev VY, Achilov AA, Popovici MI, Coats AJ, Belenkov YN. Central and peripheral components of chronic heart failure: determinants of exercise tolerance. Int J Cardiol 1999;70:51-6. 35. Franciosa JA. Exercise testing in chronic congestive heart failure. Am J Cardiol 1984;53:1447-50. 36. Franciosa JA, Park M and Levine TB. Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. Am J Cardiol 1981;47:33-9. 37. Garin O, Ferrer M, Pont A, Rue M, Kotzeva A, Wiklund I, et al. Disease-specific health-related quality of life questionnaires for heart failure: a systematic review with meta-analyses. Qual Life Res 2009;18:71-85. 38. Ghroubi S, Chaari M, Elleuch H, Massmoudi K, Abdenadher M, Trabelssi I, et al. The isokinetic assessment of peripheral muscle function in patients with coronary artery disease: correlations with cardiorespiratory capacity. Ann Readapt Med Phys 2007;50:295-301; 287-94. 39. Gleeson NP and Mercer TH. The utility of isokinetic dynamometry in the assessment of human muscle function. Sports Med 1996;21:18-34. 40. Gosker HR, Lencer NH, Franssen FM, van der Vusse GJ, Wouters EF, Schols AM. Striking similarities in systemic factors contributing to decreased exercise capacity in patients with severe chronic heart failure or COPD. Chest 2003;123:1416-24. 41. Guyatt GH, Sullivan MJ, Thompson PJ, Fallen EL, Pugsley SO, Taylor DW, et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 1985a;132:919-23. 42. Guyatt GH, Thompson PJ, Berman LB, Sullivan MJ, Townsend M, Jones NL, et al. How should we measure function in patients with chronic heart and lung disease? J Chronic Dis 1985b;38:517-24. 43. Hamaoka T, McCully KK, Quaresima V, Yamamoto K, Chance B. Near-infrared spectroscopy/imaging for monitoring muscle oxygenation and oxidative metabolism in healthy and diseased humans. J Biomed Opt 2007;12:062105. 44. Harrington D, Anker SD, Chua TP, Webb-Peploe KM, Ponikowski PP, Poole-Wilson PA, et al. Skeletal muscle function and its relation to exercise tolerance in chronic heart failure. J Am Coll Cardiol 1997;30:1758-64. 45. Harrington D and Coats AJ. Mechanisms of exercise intolerance in congestive heart failure. Curr Opin Cardiol 1997;12:224-32. 46. Hendrican MC, McKelvie RS, Smith T, McCartney N, Pogue J, Teo KK, et al. Functional capacity in patients with congestive heart failure. J Card Fail 2000;6:214-9. 47. Hlatky MA, Boineau RE, Higginbotham MB, Lee KL, Mark DB, Califf RM, et al. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol 1989;64:651-4. 48. Holloway GA, Jr. and Watkins DW. Laser Doppler measurement of cutaneous blood flow. J Invest Dermatol 1977;69:306-9. 49. Hornig B, Maier V and Drexler H. Physical training improves endothelial function in patients with chronic heart failure. Circulation 1996;93:210-4. 50. Jobsis FF. Noninvasive, infrared monitoring of cerebral and myocardial oxygen sufficiency and circulatory parameters. Science 1977;198:1264-7. 51. Johnson HM, Gossett LK, Piper ME, Aeschlimann SE, Korcarz CE, Baker TB, et al. Effects of smoking and smoking cessation on endothelial function: 1-year outcomes from a randomized clinical trial. J Am Coll Cardiol 2010;55:1988-95. 52. Katz SD, Hryniewicz K, Hriljac I, Balidemaj K, Dimayuga C, Hudaihed A, et al. Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure. Circulation 2005;111:310-4. 53. Kemps HM, Prompers JJ, Wessels B, De Vries WR, Zonderland ML, Thijssen EJ, et al. Skeletal muscle metabolic recovery following submaximal exercise in chronic heart failure is limited more by O2 delivery than O2 utilization. Clin Sci (Lond) 2010;118:203-10. 54. Kervio G, Ville NS, Leclercq C, Daubert JC, Carre F. Cardiorespiratory adaptations during the six-minute walk test in chronic heart failure patients. Eur J Cardiovasc Prev Rehabil 2004;11:171-7. 55. Kinugawa T, Kato M, Ogino K, Osaki S, Igawa O, Hisatome I, et al. Plasma endothelin-1 levels and clinical correlates in patients with chronic heart failure. J Card Fail 2003;9:318-24. 56. Knight DR, Poole DC, Schaffartzik W, Guy HJ, Prediletto R, Hogan MC, et al. Relationship between body and leg VO2 during maximal cycle ergometry. J Appl Physiol 1992;73:1114-21. 57. Krum H, Jelinek MV, Stewart S, Sindone A, Atherton JJ, Hawkes AL. Guidelines for the prevention, detection and management of people with chronic heart failure in Australia 2006. Med J Aust 2006;185:549-57. 58. Kubo SH, Rector TS, Bank AJ, Williams RE, Heifetz SM. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation 1991;84:1589-96. 59. Landis JR and Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74. 60. Lenasi H and Strucl M. Effect of regular physical training on cutaneous microvascular reactivity. Med Sci Sports Exerc 2004;36:606-12. 61. Mancini DM, Bolinger L, Li H, Kendrick K, Chance B, Wilson JR. Validation of near-infrared spectroscopy in humans. J Appl Physiol 1994;77:2740-7. 62. Mancini DM, Ferraro N, Tuchler M, Chance B, Wilson JR. Detection of abnormal calf muscle metabolism in patients with heart failure using phosphorus-31 nuclear magnetic resonance. Am J Cardiol 1988;62:1234-40. 63. Mancini DM, Walter G, Reichek N, Lenkinski R, McCully KK, Mullen JL, et al. Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 1992;85:1364-73. 64. Massari F, Mastropasqua F, Guida P, De Tommasi E, Rizzon B, Pontraldolfo G, et al. Whole-body bioelectrical impedance analysis in patients with chronic heart failure: reproducibility of the method and effects of body side. Ital Heart J 2001;2:594-8. 65. McMurray JJ and Pfeffer MA. Heart failure. Lancet 2005;365:1877-89. 66. Minotti JR, Pillay P, Oka R, Wells L, Christoph I, Massie BM. Skeletal muscle size: relationship to muscle function in heart failure. J Appl Physiol 1993;75:373-81. 67. Mohler ER, 3rd, Lech G, Supple GE, Wang H, Chance B. Impaired exercise-induced blood volume in type 2 diabetes with or without peripheral arterial disease measured by continuous-wave near-infrared spectroscopy. Diabetes Care 2006;29:1856-9. 68. Morgan DR, Dixon LJ, Hanratty CG, Hughes SM, Leahey WJ, Rooney KP, et al. Impaired endothelium-dependent and -independent vasodilation in elderly patients with chronic heart failure. Eur J Heart Fail 2004;6:901-8. 69. Myers J, Zaheer N, Quaglietti S, Madhavan R, Froelicher V, Heidenreich P. Association of functional and health status measures in heart failure. J Card Fail 2006;12:439-45. 70. Newton DJ, Khan F and Belch JJ. Assessment of microvascular endothelial function in human skin. Clin Sci (Lond) 2001;101:567-72. 71. Olsson LG, Swedberg K, Clark AL, Witte KK, Cleland JG. Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review. Eur Heart J 2005;26:778-93. 72. Palmer RM, Ferrige AG and Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-6. 73. Patel JI, Saleh GM, Hykin PG, Gregor ZJ, Cree IA. Concentration of haemodynamic and inflammatory related cytokines in diabetic retinopathy. Eye (Lond) 2008;22:223-8. 74. Pepys MB and Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003;111:1805-12. 75. Pousset F, Isnard R, Lechat P, Kalotka H, Carayon A, Maistre G, et al. Prognostic value of plasma endothelin-1 in patients with chronic heart failure. Eur Heart J 1997;18:254-8. 76. Quittan M, Wiesinger GF, Crevenna R, Nuhr MJ, Sochor A, Pacher R, et al. Isokinetic strength testing in patients with chronic heart failure--a reliability study. Int J Sports Med 2001;22:40-4. 77. Rector TS, Kubo SH and Cohn JN. Patient's self-assessment of their congestive heart failure: content, reliability and validity of the new measure, the Minnesota Living with Heart Failure questionnaire. Heart Failure 1987:198-209. 78. Riley M, McParland J, Stanford CF, Nicholls DP. Oxygen consumption during corridor walk testing in chronic cardiac failure. Eur Heart J 1992;13:789-93. 79. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, et al. Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007;115:e69-171. 80. Rossi M, Carpi A, Di Maria C, Franzoni F, Galetta F, Santoro G. Skin blood flowmotion and microvascular reactivity investigation in hypercholesterolemic patients without clinically manifest arterial diseases. Physiol Res 2009;58:39-47. 81. Rossi M, Ricco R and Carpi A. Spectral analysis of skin laser Doppler blood perfusion signal during cutaneous hyperemia in response to acetylcholine iontophoresis and ischemia in normal subjects. Clin Hemorheol Microcirc 2004;31:303-10. 82. Rostagno C, Galanti G, Comeglio M, Boddi V, Olivo G, Gastone Neri Serneri G. Comparison of different methods of functional evaluation in patients with chronic heart failure. Eur J Heart Fail 2000;2:273-80. 83. Rostagno C and Gensini GF. Six minute walk test: a simple and useful test to evaluate functional capacity in patients with heart failure. Intern Emerg Med 2008;3:205-12. 84. Roul G, Germain P and Bareiss P. Does the 6-minute walk test predict the prognosis in patients with NYHA class II or III chronic heart failure? Am Heart J 1998;136:449-57. 85. Rubin SA, Chatterjee K and Parmley WW. Metabolic assessment of exercise in chronic heart failure patients treated with short-term vasodilators. Circulation 1980;61:543-8. 86. Sallis JF, Haskell WL, Wood PD, Fortmann SP, Rogers T, Blair SN, et al. Physical activity assessment methodology in the Five-City Project. Am J Epidemiol 1985;121:91-106. 87. Schaufelberger M, Eriksson BO, Grimby G, Held P, Swedberg K. Skeletal muscle alterations in patients with chronic heart failure. Eur Heart J 1997;18:971-80. 88. Selig SE, Carey MF, Menzies DG, Patterson J, Geerling RH, Williams AD, et al. Reliability of isokinetic strength and aerobic power testing for patients with chronic heart failure. J Cardiopulm Rehabil 2002;22:282-9. 89. Shechter M, Matetzky S, Arad M, Feinberg MS, Freimark D. Vascular endothelial function predicts mortality risk in patients with advanced ischaemic chronic heart failure. Eur J Heart Fail 2009;11:588-93. 90. Shimizu Y, Yamada S, Suzuki M, Miyoshi H, Kono Y, Izawa H, et al. Development of the performance measure for activities of daily living-8 for patients with congestive heart failure: a preliminary study [Epub ahead of print]. Gerontology 2009. 91. Shoemaker JK, Naylor HL, Hogeman CS, Sinoway LI. Blood flow dynamics in heart failure. Circulation 1999;99:3002-8. 92. Smits GJ, Roman RJ and Lombard JH. Evaluation of laser-Doppler flowmetry as a measure of tissue blood flow. J Appl Physiol 1986;61:666-72. 93. Steele B. Timed walking tests of exercise capacity in chronic cardiopulmonary illness. J Cardiopulm Rehabil 1996;16:25-33. 94. Stefanovska A, Bracic M and Kvernmo HD. Wavelet analysis of oscillations in the peripheral blood circulation measured by laser Doppler technique. IEEE Trans Biomed Eng 1999;46:1230-9. 95. Sullivan MJ, Green HJ and Cobb FR. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation 1990;81:518-27. 96. Sullivan MJ, Knight JD, Higginbotham MB, Cobb FR. Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure. Muscle blood flow is reduced with maintenance of arterial perfusion pressure. Circulation 1989;80:769-81. 97. Taddei S, Virdis A, Ghiadoni L, Sudano I, Salvetti A. Effects of antihypertensive drugs on endothelial dysfunction: clinical implications. Drugs 2002;62:265-84. 98. Tew GA, Klonizakis M and Saxton JM. Effects of ageing and fitness on skin-microvessel vasodilator function in humans. Eur J Appl Physiol 2010;109:173-81. 99. Torzewski J, Hombach V and Nienhaus GU. C-reactive protein and atherosclerosis: an update. Vasc Dis Prev 2008;5:178-82. 100. Toth MJ, Gottlieb SS, Fisher ML, Poehlman ET. Skeletal muscle atrophy and peak oxygen consumption in heart failure. Am J Cardiol 1997;79:1267-9. 101. Toth MJ, Shaw AO, Miller MS, Vanburen P, Lewinter MM, Maughan DW, et al. Reduced knee extensor function in heart failure is not explained by inactivity [In press]. Int J Cardiol 2009. 102. Uszko-Lencer NH, Bothmer F, van Pol PE, Schols AM. Measuring body composition in chronic heart failure: a comparison of methods. Eur J Heart Fail 2006;8:208-14. 103. Washburn RA, Jacobsen DJ, Sonko BJ, Hill JO, Donnelly JE. The validity of the Stanford Seven-Day Physical Activity Recall in young adults. Med Sci Sports Exerc 2003;35:1374-80. 104. Williams AD, Selig S, Hare DL, Hayes A, Krum H, Patterson J, et al. Reduced exercise tolerance in CHF may be related to factors other than impaired skeletal muscle oxidative capacity. J Card Fail 2004;10:141-8. 105. Wilson JR, Martin JL, Schwartz D, Ferraro N. Exercise intolerance in patients with chronic heart failure: role of impaired nutritive flow to skeletal muscle. Circulation 1984;69:1079-87. 106. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5. 107. You Fang Z and Marwick TH. Mechanisms of exercise training in patients with heart failure. Am Heart J 2003;145:904-11. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/48412 | - |
| dc.description.abstract | 背景與目的:呼吸困難、疲勞及運動耐力不足為慢性心衰竭之典型症狀,目前研究認為運動受限原因和周邊系統功能受損有關,機制可能來自於神經內分泌和血管內在之異常,使血管阻力增加、周邊肌肉血流降低,進一步影響肌肉適能和生活功能。本研究目的在探討慢性心衰竭患者與對照之健康人和冠狀動脈疾患在膝直肌不同速度之最大等速肌力、肌耐力、下肢股內外側肌的灌流代謝、內皮功能和生活狀態的差異與其相關性。
方法:徵召21位平均年齡為62.0 ± 7.5歲男性慢性心臟衰竭患者(左心室射出率小於40%,診斷至少6個月且病情穩定3個月以上),另徵求29位平均年齡為59.9 ± 8.0歲無心衰竭之冠狀動脈疾病患者作為病人對照組,以及20位平均年齡57.0 ± 7.5歲且無心臟疾病診斷者作為健康對照組。排除條件為有骨骼肌肉系統疾病的臨床診斷,其他系統性的疾病可能會影響或不適合運動測試者。由病歷紀錄取得受試者病史、基本資訊、左心室射出率、紐約心臟學會分級及用藥情形,採集受試者血液分析內皮素-1與高敏感度C-反應蛋白。受試者接受身高、體重、身體組成和雷射都普勒血流測量儀合併離子電泳之測量,再用等速肌力儀讓受試者做三種不同角速度【慢速(60°s-1)、中速(180°s-1)和快速(240°s-1)】之最大膝伸直運動,以快速等速運動(膝蓋伸直30次)之總功評估受試者的肌耐力狀況。測試過程中同時利用近紅外線光譜偵測,計算肌肉中去氧血紅素(HHb)和組織氧飽合度(saturation)之改變量,近紅外線光譜的探頭位置為右股內、外側肌的下1/3處。受試者並接受一分鐘坐到站測試、六分鐘行走測驗,以及七日活動問卷、日常生活活動執行能力、明尼蘇達心衰竭生活狀態之問卷調查。以SPSS 13.0(SPSS Inc., Chicago, USA)進行統計分析,採用單因子變異數分析(one-way ANOVA)、無母數分析中克─瓦單因子等級變異數分析(Kruskal-Wallis one-way ANOVA by ranks)、或卡方檢定比較三組各參數之差異。並分析Ach和SNP相對改變量、肌肉灌流代謝基礎值、%改變量和半衰期時間、與肌力、肌耐力及生活功能之間的相關性,所有相關性分析皆使用淨相關分析(partial correlation),以年齡與身體活動量作為共變數。 結果:三組之基本資料相似。心衰竭患者之C-反應蛋白顯著高於冠狀動脈疾患,七日活動問卷活動量、60°s-1和180°s-1最大力矩和60°s-1和240°s-1最大力矩除以體重和生活品質均較冠狀動脈疾患差(明尼蘇打心臟衰竭問卷)。心衰竭患者之SNP血管擴張反應、在三種角速度下之最大力矩、最大力矩除以體重和肌耐力,以及五次坐到站的時間、一分鐘坐到站的次數、六分鐘行走距離亦顯著差於健康受試者;其日常生活活動執行能力的限制(PMADL-8總分),較健康受試者與冠狀動脈疾患高。骨骼肌氧合度方面,在60°s-1角速度時,心衰竭患者股內側肌組織氧飽合度回復到1/2改變量所需之時間顯著長於健康受試者;在180°s-1角速度時,心衰竭患者股外側肌與股內側肌的組織氧飽合度之%改變量/總功顯著大於健康受試者,股外側肌與股內側肌組織氧飽合度回復到1/2改變量所需之時間皆顯著長於健康受試者;在240°s-1角速度時,並無參數達顯著差異。 Ach之相對改變量與180°s-1和240°s-1之最大力矩、240°s-1總功、六分鐘行走距離呈現顯著正相關,SNP之相對改變量和240°s-1總功呈現顯著正相關。三種角速度下股外側肌之去氧血紅素基礎值皆與日常生活活動能力執行能力問卷呈顯著正相關。三種角速度下股外側和股內側肌組織氧飽合度之基礎值,除了於股外側和股內側肌60°s-1和股內側肌180°s-1與一分鐘坐到站次數無顯著差異外,其它與該速度之最大力矩、240°s-1總功、一分鐘坐到站次數、六分鐘行走測試距離呈顯著正相關,與五次坐到站時間和日常生活活動能力執行能力問卷呈顯著負相關。三種角速度之股外側肌去氧血紅素%改變量與該速度之最大力矩、240°s-1總功、五次坐到站時間、一分鐘坐到站次數呈顯著相關;股內側肌去氧血紅素%改變量則與該速度之最大力矩與日常生活活動執行能力問卷呈顯著相關。Ach與SNP之相對改變量和肌肉灌流代謝之間無顯著相關性。 結論:心衰竭患者之肌力、肌耐力、生活功能較健康受試者有下降的情況,肌力、生活功能和品質較冠狀動脈疾患差;在膝伸肌運動時氧氣傳遞能力下降,回復時間較長,代表骨骼肌代謝異常的情況,但在不同肌肉和收縮速度的表現並不一致。內皮功能、運動時肌肉去氧血紅素和休息時氧飽合度與肌肉表現和功能有相關性。 | zh_TW |
| dc.description.abstract | Background and Purpose: Shortness of breath, fatigue, and exercise intolerance are clinical symptoms of chronic heart failure (CHF). Recent studies suggested that peripheral impairment in neuroendocrine and vascular smooth muscle function was also related to their clinical symptoms. The increased peripheral resistance may influence limb blood flow, muscle fitness and activities of daily. The purposes of this study were to compare muscular strength, endurance, perfusion of quadriceps, endothelial function, and living status between CHF and coronary arterial disease (CAD) patients, as well as the healthy persons (HP), and the relations among the measured outcomes.
Methods: Twenty-one male patients with stable CHF aged 62.0 ± 7.5 years were recruited from out-patient clinics at National Taiwan University Hospital. Patients were excluded if they have any other primary diseases that may affect the testing or the results. This study also recruited 29 subjects with CAD without heart failure (mean age: 59.9 ± 8.0 years) and 20 HP (mean age: 57.0 ± 7.5 years). Medical data, including medical history, left ventricular ejection fraction, NYHA functional classification, and medication, were retrieved from the chart review. Blood sample was collected to analyze endothelin-1 and high sensitivity C-reactive protein. All subjects took an isokinetic knee extension test at 60°s-1 (5 maximal contractions), 180°s-1 (5 maximal contractions), and 240°s-1 (30 maximal contractions) by Biodex isokinetic dynamometer, and the total work of 240°s-1 was used as indice of muscule endurance. Probes of NIRS were placed at the lowest 1/3 of right vastus lateralis (VL) and vastus medialis (VM) before and during the isokinetic testing. Subjects undertook the assessment of body composition, laser Doppler flowmetry combined iontophoresis, one minute sit-to-stand test, 6-minute walking test (6MWT), and filled in the questionnaire of 7-day recall physical activity questionnaire, Performance Measure for Activities of Daily Living-8 (PMADL-8), and Minnesota Living with Heart Failure Questionnaire (LHFQ). Group comparsions were made using one-way ANOVA or Kruskal-Wallis one-way ANOVA or chi-square test. The relationship among the relative change of Ach and SNP, resting and % change of HHb and saturation, muscle strength, endurance, one minute sit-to-stand test, 6MWT, and PDML-8 were analyzed by partial correlation coefficient, while age and physical activity were used as covariates. Results: The basic characteristics were similar among the three groups. Subjects in CHF group had higher CRP and lower physical activity, peak torque at 60°s-1 and 180°s-1, and also lower peak torque divided by body weight at 60°s-1 and 240°s-1 than CAD. Significantly lower SNP response, muscle strength and endurance, and sit-to-stand and 6MWT were noted in CHF than HP. CHF subjects had higher scores in PMADL-8 than HP and CAD and higher LHFQ scores than CAD, the lower values in PMADL-8 and LHFQ indicated better performance or quality. CHF had significantly longer recovery time in saturation (only VM) at 60°s-1, higher % change/work and longer recovery time of saturation (VL and VM) at 180°s-1 than HP. There was no significant difference in HHb or saturation at 240°s-1 for any between group comparsions. Relative change of Ach was positively correlated with peak torque at 180°s-1 and 240°s-1, total work of 240°s-1, and 6MWT. Relative change of SNP was significantly correlated with total work of 240°s-1. The baseline values of HHb in VL and VM were significantly correlated with PMADL-8. The baseline values of saturation in VL and VM were significantly correlated with peak torque, total work of 240°s-1, duration of 5 times sit-to-stand test, times of one minute sit-to-stand test, 6MWT, and PMADL-8, except 60°s-1 (VL and VM) and 180°s-1 (only VM) showed no significantly correlated with one minute sit-to-stand test. The % change of HHb in VL was only significantly correlated with peak torque, total work of 240°s-1, sit-to-stand test. The % change of HHb in VM was also significantly correlated with peak torque and PMADL-8. The relative change of Ach and SNP were not correlated significantly with HHb or saturation. Conclusion: Muscle strength, functional performance and quality of life were decreased in CHF compared with CAD. Oxygen saturation of quadriceps was decreased, and recovery time was prolonged in CHF. It suggested skeletal muscle metabolism was impaired in CHF; however, it was not consistent in different muscles or speed of contraction. Endothelial function indicated by Ach response, muscle HHb and O2 saturation had some correlations with their muscle and functional performance. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-15T06:55:48Z (GMT). No. of bitstreams: 1 ntu-100-R97428012-1.pdf: 4443030 bytes, checksum: b7543ba8d133e780f3d2b0ddd5c349b0 (MD5) Previous issue date: 2011 | en |
| dc.description.tableofcontents | 目 錄
口試委員審定書 i 誌謝 ii 中文摘要 iii 英文摘要 v 目 錄 viii 第一章、前言 1 第一節、研究背景 1 第二節、研究目的 2 第三節、本研究之操作型定義 3 第四節、研究之重要性 4 第二章、文獻回顧 5 第一節、慢性心衰竭患者介紹 5 第二節、心衰竭患者之內皮功能和周邊代謝能力 6 第三節、慢性心衰竭患者之骨骼肌肌力和肌耐力 9 第四節、慢性心衰竭患者之骨骼肌功能 11 第五節、近紅外線光譜於心衰竭患者之應用 12 第六節、慢性心衰竭患者之生活功能 15 第三章、研究方法及實驗步驟 16 第一節、研究設計 16 第二節、受試者人口統計學資料 16 第三節、研究步驟 17 第四節、研究工具及方法 17 第五節、資料處理與統計分析 25 第四章、研究結果 26 第一節、血液相關發炎參數與雷射都卜勒測量結果 26 第二節、等速肌力測試與簡易功能評估結果 26 第三節、骨骼肌氧合度於等速肌力測試之反應 27 第四節、相關性分析 27 第五章、討論 30 第一節、心衰竭患者之血液相關發炎參數與內皮細胞功能比較 31 第二節、心衰竭患者等速肌力測試與簡易功能評估結果 33 第三節、心衰竭患者肌肉灌流代謝於等速肌力測試之反應 36 第四節、研究限制 39 第六章、結論 41 參考文獻 42 圖表目錄 表1. 心臟衰竭患者之肌力與肌耐力 48 表2. 心臟衰竭患者之內皮功能不全 51 表3. 近紅外線光譜於心臟衰竭患者之應用 55 表4. 受試者基本資料 58 表5. 冠狀動脈疾病患者與心衰竭患者之共病症與用藥 59 表6. 血液生化參數 61 表7. 雷射都普勒血流測量儀合併離子電泳測量之內皮功能結果 62 表8. 等速肌力測試與簡易功能評估結果 63 表9. 等速肌力測試角速度60°s-1時,股外側肌與股內側肌之組間比較 65 表10. 等速肌力測試角速度180°s-1時,股外側肌與股內側肌之組間比較 67 表11. 等速肌力測試角速度240°s-1時,股外側肌與股內側肌之組間比較 69 表16. 內皮功能改變量與肌肉灌流代謝改變量之相關性分析 78 圖1. 骨骼肌肉功能異常之假說機制 79 圖2. 收案流程圖 80 圖3. 等速肌力測試流程圖 81 圖4. 三種角速度之等速肌力圖 82 圖5. 雷射都卜勒合併離子電泳訊號圖 83 圖6. 近紅外線光譜訊號圖 85 附錄 附錄一、紐約心臟學會功能性分級 86 附錄二、七日活動問卷 87 附錄三、日常生活活動執行能力問卷(PMADL-8) 89 附錄四、明尼蘇打心臟衰竭問卷(MHFQ) 90 附錄五、受試者基本資料表 91 附錄六、國立台灣大學醫學院附設醫院研究倫理委員會同意函 93 附錄七、心衰竭患者紐約心臟學會第一級與第二、三級比較 94 | |
| dc.language.iso | zh-TW | |
| dc.subject | 生活功能 | zh_TW |
| dc.subject | 慢性心衰竭 | zh_TW |
| dc.subject | 等速肌力測試 | zh_TW |
| dc.subject | 近紅外線光譜 | zh_TW |
| dc.subject | 內皮功能 | zh_TW |
| dc.subject | physical function | en |
| dc.subject | endothelial function | en |
| dc.subject | near-infrared spectroscopy | en |
| dc.subject | isokinetic test | en |
| dc.subject | chronic heart failure | en |
| dc.title | 慢性心衰竭患者內皮功能、下肢肌肉表現與代謝能力和生活功能之探討 | zh_TW |
| dc.title | Endothelial Function, Muscular Performance and Metabolism, and Physical Function in Patients with Chronic Heart Failure | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 99-1 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 李啟明,吳彥雯,蔡美文 | |
| dc.subject.keyword | 慢性心衰竭,等速肌力測試,近紅外線光譜,內皮功能,生活功能, | zh_TW |
| dc.subject.keyword | chronic heart failure,isokinetic test,,near-infrared spectroscopy,endothelial function,physical function, | en |
| dc.relation.page | 103 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2011-02-09 | |
| dc.contributor.author-college | 醫學院 | zh_TW |
| dc.contributor.author-dept | 物理治療學研究所 | zh_TW |
| 顯示於系所單位: | 物理治療學系所 | |
文件中的檔案:
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-100-1.pdf 未授權公開取用 | 4.34 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。
